Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial of Active Cellular Immunotherapy With Preparation DCVAC/PCa in Combination With Hormone Therapy in Patients With Metastatic Prostate Cancer

NCT02107391 is registered in ClinicalTrials.gov with SOTIO a.s. as lead sponsor.

NCT NCT02107391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02107391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial of Active Cellular Immunotherapy With Preparation DCVAC/PCa in Combination With Hormone Therapy in Patients With Metastatic Prostate Cancer
Lead sponsor
SOTIO a.s.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
June 30, 2016
Enrollment
63 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer